It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Oxidative stress has been considered the main contributor to liver injury. Dietary antioxidants would be expected to improve liver function. The hepatoprotective effects of antioxidants are controversial. In the present study, the associations of some dietary antioxidants and the levels of serum liver enzymes were examined. This cross-sectional study was conducted using the Rafsanjan Cohort Study (RCS) data as a population-based prospective cohort which is a part of the Prospective Epidemiological Research Studies in IrAN (PERSIAN). A total of 9942 participants aged 35–70 years old were included in this study. Among this population, 4631 (46.59%) were male, and 5311 (53.42%) were female. Dietary intakes were collected by a validated food frequency questionnaire (FFQ) with 128 items. Aspartate transaminase (AST), Alanine transaminase (ALT), γ-glutamyl transferase (GGT), and Alkaline phosphatase (ALP) were measured by a biotecnica analyzer. Dichotomous logistics regression models were used to investigate the association between the elevated liver enzymes and intake of dietary antioxidants using crude and adjusted models. In the adjusted model, in subjects with higher consumption of Se, Vit A, Vit E, β-carotene, α-carotene, and β-cryptoxanthin, the odds ratios of elevated ALP were decreased compared to the reference group (ORs 0.79 (0.64–0.96), 0.80 (0.66–0.98), 0.73 (0.60–0.89), 0.79 (0.64–0.96), 0.78 (0.64–0.95), 0.80 (0.66–0.98), and 0.79 (0.64–0.98), respectively). Subjects with higher consumption of Se, Vit A, Vit E, and provitamin A carotenoids (β-carotene, α-carotene, β-cryptoxanthin) showed decreased odds of elevated ALP. These findings support the hypothesis that Se, Vit A, Vit E, and provitamin A carotenoids may be associated with improvements in ALP and act as suppressors against the development of liver injury.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Rafsanjan University of Medical Sciences, Clinical Research Development Unit (CRDU), Ali-Ibn Abi-Talib Hospital, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Rafsanjan University of Medical Sciences, Department of Pathology, Medical School, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
2 Rafsanjan University of Medical Sciences, Immunology of Infectious Diseases Research Center, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
3 Shahid Beheshti University of Medical Sciences, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran, Iran (GRID:grid.411600.2); Shahid Beheshti University of Medical Sciences, Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran, Iran (GRID:grid.411600.2)
4 Rafsanjan University of Medical Sciences, Social Determinants of Health Research Center, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Rafsanjan University of Medical Sciences, Department of Epidemiology, School of Public Health, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
5 Rafsanjan University of Medical Sciences, Non-Communicable Diseases Research Center, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
6 Rafsanjan University of Medical Sciences, Neurology Department, School of Medicine, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Rafsanjan University of Medical Sciences, Clinical Research Development Unit (CRDU), Moradi Hospital, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
7 Rafsanjan University of Medical Sciences, Non-Communicable Diseases Research Center, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Rafsanjan University of Medical Sciences, Clinical Research Development Unit (CRDU), Niknafs Hospital, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)




